文献速递关节外科创伤骨科

链球菌假体周围关节感染治疗失败率高:一项七年回顾性队列研究结果

High failure rates in treatment of streptococcal periprosthetic joint infection: results from a seven-year retrospective cohort study.
PubMed 文献 · Bone Joint J · 2017-01-01

该回顾性队列研究分析了2009年1月至2015年12月间30例链球菌假体周围关节感染(PJI)患者(12例髋、18例膝)的治疗结局。中位随访39.2个月,三年无感染生存率为59%(95%CI 39%~75%),治疗失败均发生在治疗后第一年内。作者结论认为链球菌PJI治疗成功率低(18/30,59%),需要新的治疗策略。

要点

  • 30例链球菌PJI中,感染无生存三年为59%(95%CI 39%~75%),治疗失败均在治疗后第一年内出现。
  • 二期翻修关节成形术治疗22例中10例失败(45%),清创保留假体6例中2例失败(33%),一期翻修2例均无失败。
  • 含或不含利福平的抗生素方案治疗链球菌PJI的结局无差异(p=0.175)。

核心结论

  • 作者结论认为其队列中链球菌PJI治疗成功率低(18/30,59%),需要新的治疗链球菌PJI的方法。

研究设计与样本

  • 回顾性队列研究,从临床数据库识别2009年1月至2015年12月间发生的链球菌PJI病例。
  • 共纳入30例链球菌PJI(30例患者),其中12例为全髋关节置换术后、18例为全膝关节置换术后。
  • 采用Kaplan-Meier生存法估计无感染生存概率,并评估生物膜活性抗生素利福平的影响。

主要发现

  • 16例感染被认为经血源性获得,14例为围手术期获得。
  • 成功治疗病例的中位随访时间为39.2个月(12~75),治疗失败均发生在治疗后第一年内。
  • 三年无感染生存率为59%(95%置信区间39%~75%),有12例患者处于风险中。
  • 二期翻修关节成形术治疗的22例PJI中10例失败(45%),清创保留假体治疗的6例中2例失败(33%),一期翻修关节成形术治疗的2例均无失败。
  • 含或不含利福平的抗生素方案治疗链球菌PJI的治疗结局无差异(p=0.175)。

关键数值与推荐

  • 三年无感染生存率59%(95%CI 39%~75%),12例处于风险中。
  • 二期翻修关节成形术失败10/22(45%),清创保留假体失败2/6(33%),一期翻修失败0/2。
  • 含利福平与不含利福平方案的治疗结局比较p=0.175。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate the outcomes of treatment of streptococcal periprosthetic joint infection (PJI) involving total knee and hip arthroplasties. PATIENTS AND METHODS: Streptococcal PJI episodes which occurred between January 2009 and December 2015 were identified from clinical databases. Presentation and clinical outcomes for 30 streptococcal PJIs in 30 patients (12 hip and 18 knee arthroplasties) following treatment were evaluated from the medical notes and at review. The Kaplan-Meier survival method was used to estimate the probability of infection-free survival. The influence of the biofilm active antibiotic rifampin was also assessed. RESULTS: The infection was thought to have been acquired haematogenously in 16 patients and peri-operatively in 14. The median follow-up time for successfully treated cases was 39.2 months (12 to 75), whereas failure of the treatment occurred within the first year following treatment on every occasion. The infection-free survival at three years with 12 patients at risk was 59% (95% confidence interval 39% to 75%). Failure of the treatment was observed in ten of 22 PJIs (45%) treated with a two-stage revision arthroplasty, two of six (33%) treated by debridement and prosthesis retention, and in neither of the two PJIs treated with one-stage revision arthroplasty. Streptococcal PJI treated with or without rifampin included in the antibiotic regime showed no difference in treatment outcome (p = 0.175). CONCLUSION: The success of treatment of streptococcal PJI in our patient cohort was poor (18 of 30 cases, 59%). New therapeutic approaches for treating streptococcal PJI are needed. Cite this article: Bone Joint J 2017;99-B:653-9.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Akgün D, Trampuz A, Perka C, et al. High failure rates in treatment of streptococcal periprosthetic joint infection: results from a seven-year retrospective cohort study. Bone Joint J. 2017. PMID: 28455475. doi:10.1302/0301-620X.99B5.BJJ-2016-0851.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。